Drugs / Type 1 interferon
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00436046 | Mar → Apr 2007 | influenza | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Type 1 interferon | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00436046 ↗ |
| Known as | IFN | “Type 1 interferon (IFN)” NCT00436046 ↗ |
| Modality | Protein / enzyme biologic | “type 1 interferon (a protein that helps the immune system fight viruses)” NCT00436046 ↗ |
| Route | Intranasal | “including type 1 IFN with IVV, administered intranasally” NCT00436046 ↗ |